Daily Bulletin

Men's Weekly

.

NEW THERAPY TO TREAT RARE GASTROINTESTINAL STROMAL TUMOUR APPROVED FOR NEW ZEALAND PATIENTS

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
NEW THERAPY TO TREAT RARE GASTROINTESTINAL STROMAL TUMOUR APPROVED FOR NEW ZEALAND PATIENTS
  • QINLOCK® (ripretinib) now Medsafe approved for GIST patients in NZ
  • QINLOCK now being considered by PHARMAC for reimbursement
  • Data from the INVICTUS Phase 3 study shows QINLOCK reduces risk of disease progression or death by 85%1, 2

SINGAPORE and AUCKLAND, New Zealand, Jan. 20, 2023 /PRNewswire/ -- Independent biopharmaceutical company...

Read more: NEW THERAPY TO TREAT RARE GASTROINTESTINAL STROMAL TUMOUR APPROVED FOR NEW ZEALAND PATIENTS

Business News

Integrating Marketing Automation Workflows with Headless CMS: Creating a Unified Engine for Scalable Growth

Marketing automation is a necessary component of modern engagement with customers. Automated emails, triggered campaigns, lead nurturing and lifecycle messaging enable brands to scale their messagin...

Daily Bulletin - avatar Daily Bulletin

Why Split Corrugated Conduits Are Essential For Protecting Electrical And Solar Installations

Modern electrical systems require reliable protection for wiring and cables to ensure safety, durability, and long-term performance. In residential, commercial, and industrial environments, conduits a...

Daily Bulletin - avatar Daily Bulletin

Launching Global Product Campaigns with Decoupled Content Architecture

There's perhaps no more challenging project for an international enterprise to pursue than a global product launch campaign. At the same time, various regions, languages, compliance standards, digit...

Daily Bulletin - avatar Daily Bulletin

Speed Dating For Business